These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29060672)

  • 1. Design and construction of a synthetic E. coli protease inhibitor detecting biomachine.
    Boonyalekha P; Meechai A; Tayapiwatana C; Kitidee K; Waraho-Zhmayev D
    Annu Int Conf IEEE Eng Med Biol Soc; 2017 Jul; 2017():3580-3583. PubMed ID: 29060672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.
    Ghosh AK; Chapsal BD; Weber IT; Mitsuya H
    Acc Chem Res; 2008 Jan; 41(1):78-86. PubMed ID: 17722874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model system for high-throughput screening of novel human immunodeficiency virus protease inhibitors in Escherichia coli.
    Cheng TJ; Brik A; Wong CH; Kan CC
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2437-47. PubMed ID: 15215092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications.
    Amano M; Salcedo-Gómez PM; Yedidi RS; Zhao R; Hayashi H; Hasegawa K; Nakamura T; Martyr CD; Ghosh AK; Mitsuya H
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli.
    Louis JM; McDonald RA; Nashed NT; Wondrak EM; Jerina DM; Oroszlan S; Mora PT
    Eur J Biochem; 1991 Jul; 199(2):361-9. PubMed ID: 2070793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
    Lefebvre E; Schiffer CA
    AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of HIV-1 protease activity by use of crude preparations of enzyme and biotinylated substrate.
    Yu SL; Wang N; Liou CY; Syu WJ
    J Virol Methods; 1995 May; 53(1):63-73. PubMed ID: 7635927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 protease substrate-groove: Role in substrate recognition and inhibitor resistance.
    Laco GS
    Biochimie; 2015 Nov; 118():90-103. PubMed ID: 26300060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of in vivo HIV protease activity using genetically engineered QD-based FRET probes.
    Cella LN; Biswas P; Yates MV; Mulchandani A; Chen W
    Biotechnol Bioeng; 2014 Jun; 111(6):1082-7. PubMed ID: 24473897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid and sensitive bacterial assay to determine the inhibitory effect of 'interface' peptides on HIV-1 protease co-expressed in Escherichia coli.
    Ast O; Jentsch KD; Schramm HJ; Hunsmann G; Lüke W; Petry H
    J Virol Methods; 1998 Mar; 71(1):77-85. PubMed ID: 9628224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor.
    el-Farrash MA; Kuroda MJ; Kitazaki T; Masuda T; Kato K; Hatanaka M; Harada S
    J Virol; 1994 Jan; 68(1):233-9. PubMed ID: 8254733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.
    Koh Y; Das D; Leschenko S; Nakata H; Ogata-Aoki H; Amano M; Nakayama M; Ghosh AK; Mitsuya H
    Antimicrob Agents Chemother; 2009 Mar; 53(3):997-1006. PubMed ID: 18955518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
    Erickson-Viitanen S; Manfredi J; Viitanen P; Tribe DE; Tritch R; Hutchison CA; Loeb DD; Swanstrom R
    AIDS Res Hum Retroviruses; 1989 Dec; 5(6):577-91. PubMed ID: 2692658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An E. coli expression system which detoxifies the HIV protease.
    Korant BD; Rizzo CJ
    Biomed Biochim Acta; 1991; 50(4-6):643-6. PubMed ID: 1801736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of inhibitors of HIV-1 protease using an Escherichia coli cell assay.
    Büttner J; Dornmair K; Schramm HJ
    Biochem Biophys Res Commun; 1997 Apr; 233(1):36-8. PubMed ID: 9144391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
    Nalam MN; Ali A; Altman MD; Reddy GS; Chellappan S; Kairys V; Ozen A; Cao H; Gilson MK; Tidor B; Rana TM; Schiffer CA
    J Virol; 2010 May; 84(10):5368-78. PubMed ID: 20237088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the full length HIV-1 Gag polyprotein reveals the role of its p6 subunit in viral maturation and the effect of non-cleavage site mutations in protease drug resistance.
    Su CT; Kwoh CK; Verma CS; Gan SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4366-4377. PubMed ID: 29237328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease.
    Ohtaka H; Velázquez-Campoy A; Xie D; Freire E
    Protein Sci; 2002 Aug; 11(8):1908-16. PubMed ID: 12142445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism.
    Nijhuis M; van Maarseveen NM; Lastere S; Schipper P; Coakley E; Glass B; Rovenska M; de Jong D; Chappey C; Goedegebuure IW; Heilek-Snyder G; Dulude D; Cammack N; Brakier-Gingras L; Konvalinka J; Parkin N; Kräusslich HG; Brun-Vezinet F; Boucher CA
    PLoS Med; 2007 Jan; 4(1):e36. PubMed ID: 17227139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Hierarchical Virtual Screening To Combat Drug Resistance of the HIV-1 Protease.
    Li N; Ainsworth RI; Ding B; Hou T; Wang W
    J Chem Inf Model; 2015 Jul; 55(7):1400-12. PubMed ID: 25993532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.